Oncology

In this context, the role of a central lab is paramount with the development of companion diagnostics and biomarkers discoveries. In addition, the pressure regarding turn around time (TAT) has increased whilst studies have globalized with the need for specific genetic characteristics.

BARC provides a comprehensive service offering in oncology, both in terms of human expertise and integrated techniques. Our experience in companion diagnostic development for targeted therapies as well as for host-related genomics are key for offering a translational approach in the development and validation of new biomarkers and for implementing technology transfers with our customers.

 In addition, our network of medical labs and specimen sourcing divisions in our parent company, Cerba European Lab, ensures both medical expertise of regional situations and interactions with physicians and healthcare organizations in all countries where Cerba European Lab operates on a daily basis for medical purposes.